These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 29027)

  • 41. In vitro evaluation of cefoxitin sodium: clinical implications.
    Stamboulian D; Sarachian B
    J Antimicrob Chemother; 1978 Jul; 4(B):65-8. PubMed ID: 690026
    [No Abstract]   [Full Text] [Related]  

  • 42. Prevalence and in vitro sensitivity of Enterobacteriaceae to cefoxitin and new cephalosporins.
    Van Landuyt HW; Pyckavet M; Vuye A
    Acta Clin Belg; 1979; 34(4):202-7. PubMed ID: 525199
    [No Abstract]   [Full Text] [Related]  

  • 43. Bactericidal activity of cefoxitin and cefuroxime.
    Shah PM; Bender H
    J Antimicrob Chemother; 1978 Mar; 4(2):163-8. PubMed ID: 649537
    [No Abstract]   [Full Text] [Related]  

  • 44. Discrepant behaviour of clotrimazole against Bacteroides fragilis in liquid and solid media.
    Reynolds AV; Hamilton-Miller JM; Brumfitt W
    J Antimicrob Chemother; 1977 Nov; 3(6):622-4. PubMed ID: 599124
    [No Abstract]   [Full Text] [Related]  

  • 45. Effect of carbon dioxide and pH on susceptibility of Bacteroides fragilis group to erythromycin.
    Hansen SL; Swomley P; Drusano G
    Antimicrob Agents Chemother; 1981 Feb; 19(2):335-6. PubMed ID: 6812492
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Letter: Bacteroides fragilis and spectinomycin.
    Ferguson IR; Smith LL
    J Antimicrob Chemother; 1975 Jun; 1(2):245-6. PubMed ID: 126220
    [No Abstract]   [Full Text] [Related]  

  • 47. Formation of glycosidases in batch and continuous culture of Bacteroides fragilis.
    Berg JO; Nord CE; Wadström T
    Appl Environ Microbiol; 1978 Feb; 35(2):269-73. PubMed ID: 25044
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects on renal function of treatment with cefoxitin sodium alone or in combination with furosemide.
    Trollfors B; Norrby R; Kristianson K
    J Antimicrob Chemother; 1978 Jul; 4(B):85-9. PubMed ID: 99419
    [No Abstract]   [Full Text] [Related]  

  • 49. Fluorimetric assay of cefoxitin.
    Al-Rawi ZH; Tabaqchali S
    J Antimicrob Chemother; 1979 Jan; 5(1):81-6. PubMed ID: 33143
    [No Abstract]   [Full Text] [Related]  

  • 50. A miniature anaerobic jar for tissue transport or for cultivation of anaerobes.
    Attebery HR; Finegold SM
    Am J Clin Pathol; 1970 Mar; 53(3):383-8. PubMed ID: 4906696
    [No Abstract]   [Full Text] [Related]  

  • 51. In vitro activity of cefoxitin against Nocardia spp. and Actinomadura spp.
    Garcia-Rodriguez JA; Gomez-Garcia AC; Martin-Luengo FM
    J Antimicrob Chemother; 1979 Sep; 5(5):616-8. PubMed ID: 500519
    [No Abstract]   [Full Text] [Related]  

  • 52. The effect of pH and potassium phosphate buffer on the toxicity of cadmium for bacteria.
    Korkeala H; Pekkanen TJ
    Acta Vet Scand; 1978; 19(1):93-101. PubMed ID: 26194
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An efficient general-purpose culture medium for aerobes and anaerobes.
    Khairat O
    Can J Microbiol; 1966 Apr; 12(2):323-31. PubMed ID: 5333358
    [No Abstract]   [Full Text] [Related]  

  • 54. Comparative in vitro studies of Ro 13-9904, a new cephalosporin derivative.
    Eickhoff TC; Ehret J
    Antimicrob Agents Chemother; 1981 Mar; 19(3):435-42. PubMed ID: 6264845
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparative in vitro activity of 1-oxa-beta-lactam (LY127935) and cefoperazone with other beta-lactam antibiotics against anaerobic bacteria.
    Borobio MV; Aznar J; Jimenez R; Garcia F; Perea EJ
    Antimicrob Agents Chemother; 1980 Feb; 17(2):129-31. PubMed ID: 6247966
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vitro activity of LY127935.
    Barza M; Tally FP; Jacobus NV; Gorbach SL
    Antimicrob Agents Chemother; 1979 Sep; 16(3):287-92. PubMed ID: 507785
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cefoxitin: a review of its antibacterial activity, pharmacological properties and therapeutic use.
    Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1979 Jan; 17(1):1-37. PubMed ID: 369806
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cefoxitin sodium activity against anaerobes: effect of the inoculum size, pH variation and different culture media.
    Perea EJ; Aznar J; Garcia-Iglesias MC; Borobio MV
    J Antimicrob Chemother; 1978 Jul; 4(B):55-60. PubMed ID: 29027
    [No Abstract]   [Full Text] [Related]  

  • 59. Comparison of the inoculum effect of cefoxitin and other cephalosporins and of beta-lactamase inhibitors and their penicillin-derived components on the Bacteroides fragilis group.
    Goldstein EJ; Citron DM; Cherubin CE
    Antimicrob Agents Chemother; 1991 Sep; 35(9):1868-74. PubMed ID: 1952860
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Susceptibility of anaerobic bacteria to cefoxitin (author's transl)].
    Freydière AM; Gille Y; Marcel JP; Vincent P
    Sem Hop; 1980 Nov 18-25; 56(43-44):1793-5. PubMed ID: 6256880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.